Author

Katlin Recabo

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Bernat GeliD· 1 shared Cleofé RomagosaiD· 1 shared Conxi LázaroiD· 1 shared Crystal McKnight· 1 shared Edgar Creus‐BachilleriD· 1 shared Eduard SerraiD· 1 shared Emily Lee· 1 shared Héctor SalvadoriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bernat GelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

iPSC-derived NF1-CDKN2A-PRC2 deficient neural crest mimics MPNST glial-to-neuro-mesenchymal transition and uncover new therapeutic opportunities

Itziar Uriarte-Arrazola, Miriam Magallón‐Lorenz, Juana Fernández‐Rodríguez, Jiajing Zhang, Emily Lee, Sara Ortega‐Bertran, Edgar Creus‐Bachiller, Judit Farrés-Casas, Kelli M. Wilson, Crystal McKnight, Katlin Recabo, Ignacio Blanco, Héctor Salvador, Cleofé Romagosa, Conxi Lázaro, , Eduard Serra

This paper uses iPSC-derived neural crest models to mimic MPNST progression and identifies PARPi as a potential therapy for PRC2-deficient tumors.

bioRxiv · Aug 13, 2025 · PreprintCancer Biology